Dobutamine Stress Echocardiography Compared with Coronary Computed Tomography Angiography in Screening for Coronary Artery Disease in End-Stage Liver Disease Patients Being Assessed for Liver Transplantation

Background: Patients with end-stage liver disease (ESLD) and coronary artery disease (CAD) are at increased perioperative risk during liver transplantation. Both non–invasive functional imaging with dobutamine stress echocardiography (DSE) and non–invasive anatomical imaging with computed tomography coronary angiography (CTCA) are used to screen for CAD, but their effect on perioperative management is unclear.